These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 11160242)

  • 1. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
    Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
    J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of MD-2 in TLR2- and TLR4-mediated recognition of Gram-negative and Gram-positive bacteria and activation of chemokine genes.
    Dziarski R; Gupta D
    J Endotoxin Res; 2000; 6(5):401-5. PubMed ID: 11521063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.
    Takeuchi O; Hoshino K; Kawai T; Sanjo H; Takada H; Ogawa T; Takeda K; Akira S
    Immunity; 1999 Oct; 11(4):443-51. PubMed ID: 10549626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components.
    Talreja J; Kabir MH; B Filla M; Stechschulte DJ; Dileepan KN
    Immunology; 2004 Oct; 113(2):224-33. PubMed ID: 15379983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling.
    Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y
    J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS.
    Laflamme N; Soucy G; Rivest S
    J Neurochem; 2001 Nov; 79(3):648-57. PubMed ID: 11701768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4.
    Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN
    J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.
    Akashi S; Shimazu R; Ogata H; Nagai Y; Takeda K; Kimoto M; Miyake K
    J Immunol; 2000 Apr; 164(7):3471-5. PubMed ID: 10725698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from gram-negative and gram-positive bacteria.
    Laflamme N; Echchannaoui H; Landmann R; Rivest S
    Eur J Immunol; 2003 Apr; 33(4):1127-38. PubMed ID: 12672079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
    Yoshimura A; Lien E; Ingalls RR; Tuomanen E; Dziarski R; Golenbock D
    J Immunol; 1999 Jul; 163(1):1-5. PubMed ID: 10384090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
    Schwandner R; Dziarski R; Wesche H; Rothe M; Kirschning CJ
    J Biol Chem; 1999 Jun; 274(25):17406-9. PubMed ID: 10364168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition.
    Akashi S; Nagai Y; Ogata H; Oikawa M; Fukase K; Kusumoto S; Kawasaki K; Nishijima M; Hayashi S; Kimoto M; Miyake K
    Int Immunol; 2001 Dec; 13(12):1595-9. PubMed ID: 11717200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.
    Abreu MT; Vora P; Faure E; Thomas LS; Arnold ET; Arditi M
    J Immunol; 2001 Aug; 167(3):1609-16. PubMed ID: 11466383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades.
    Takeuchi O; Takeda K; Hoshino K; Adachi O; Ogawa T; Akira S
    Int Immunol; 2000 Jan; 12(1):113-7. PubMed ID: 10607756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
    Bulut Y; Faure E; Thomas L; Equils O; Arditi M
    J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
    Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
    J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.
    Melmed G; Thomas LS; Lee N; Tesfay SY; Lukasek K; Michelsen KS; Zhou Y; Hu B; Arditi M; Abreu MT
    J Immunol; 2003 Feb; 170(3):1406-15. PubMed ID: 12538701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
    Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
    Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation.
    Faure E; Thomas L; Xu H; Medvedev A; Equils O; Arditi M
    J Immunol; 2001 Feb; 166(3):2018-24. PubMed ID: 11160251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.